Medtronic plc logo
Medtronic plc (MDT)
Compare

Medtronic plc (MDT) EV/Assets Ratio: 1.42x

Is Medtronic plc’s EV/Assets ratio high or low?

Medtronic plc's EV/Assets ratio of 1.42x is 11% below its 5-year average of 1.60x, near the low end of its 5-year range (1.28x–2.25x).

The EV/Assets ratio for Medtronic plc (MDT) is 1.42x as of Wednesday, June 10, 2026. It is below its 12-month average by 10.71% (1.59x).

MDT EV/Assets Ratio Chart

MDT EV/Assets Ratio
1.42x-7.79% 1Y
Zoom

MDT Average EV/Assets Ratio Chart

MDT Current vs Average EV/Assets Ratio Chart

MDT EV/Assets Ratio Metrics

EV/ASSETS RATIO

1.42x

EV/ASSETS RATIO AVG TTM

1.59x

EV/ASSETS RATIO AVG 3Y

1.53x

EV/ASSETS RATIO AVG 5Y

1.60x

EV/ASSETS RATIO AVG 10Y

1.61x

EV/ASSETS RATIO AVG 15Y

1.63x

EV/ASSETS RATIO AVG 20Y

1.83x

CURRENT VS TTM AVG

-10.71%

CURRENT VS 3Y AVG

-6.98%

CURRENT VS 5Y AVG

-11.09%

CURRENT VS 10Y AVG

-11.81%

CURRENT VS 15Y AVG

-12.73%

CURRENT VS 20Y AVG

-22.55%

MDT Competitors' EV/Assets Ratio

NAMEMARKET CAPEV/ASSETS RATIOTTM3Y5Y
Medtronic plc (MDT)1.42x1.59x1.53x1.60x
Vertex Pharmaceuticals Incorporated (VRTX)$110.77B4.10x4.45x4.69x4.46x
Bristol-Myers Squibb Company (BMY)$114.14B1.72x1.55x1.56x1.64x
Elevance Health Inc. (ELV)$87.43B0.88x0.80x1.03x1.13x
CVS Health Corporation (CVS)$125.16B0.77x0.67x0.63x0.70x
Cigna Corporation (CI)$78.25B0.67x0.66x0.72x0.73x
Danaher Corporation (DHR)$130.25B1.72x1.98x2.16x2.26x
Regeneron Pharmaceuticals, Inc. (REGN)$62.59B1.60x1.82x2.51x2.70x
Pfizer Inc. (PFE)$146.36B1.01x1.00x1.03x1.28x
Intuitive Surgical, Inc. (ISRG)$146.44B7.30x8.88x9.09x8.50x

Medtronic plc EV/Assets Ratio Formula & Definition

EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Medtronic plc EV/Assets Ratio FAQ

What is the EV/Assets ratio for Medtronic plc (MDT)?
The EV/Assets ratio for MDT stock is 1.42x.
Is Medtronic plc's EV/Assets ratio high or low?
Medtronic plc's EV/Assets ratio of 1.42x is 11% below its 5-year average of 1.60x, near the low end of its 5-year range (1.28x–2.25x).
What is the TTM average EV/Assets ratio for Medtronic plc (MDT)?
The TTM average EV/Assets ratio for MDT stock is 1.59x.
What is the 3Y average EV/Assets ratio for Medtronic plc (MDT)?
The 3Y average EV/Assets ratio for MDT stock is 1.53x.
What is the 5Y average EV/Assets ratio for Medtronic plc (MDT)?
The 5Y average EV/Assets ratio for MDT stock is 1.60x.
What is the 10Y average EV/Assets ratio for Medtronic plc (MDT)?
The 10Y average EV/Assets ratio for MDT stock is 1.61x.
What is the 15Y average EV/Assets ratio for Medtronic plc (MDT)?
The 15Y average EV/Assets ratio for MDT stock is 1.63x.
What is the 20Y average EV/Assets ratio for Medtronic plc (MDT)?
The 20Y average EV/Assets ratio for MDT stock is 1.83x.

Medtronic plc EV/Assets Ratio History

DATEEV/ASSETS RATIO
2026-06-101.42x
2026-06-091.45x
2026-06-081.43x
2026-06-051.44x
2026-06-041.45x
2026-06-031.39x
2026-06-021.33x
2026-06-011.34x
2026-05-291.33x
2026-05-281.36x
2026-05-271.36x
2026-05-261.39x
2026-05-221.40x
2026-05-211.39x
2026-05-201.39x
2026-05-191.40x
2026-05-181.38x
2026-05-151.37x
2026-05-141.38x
2026-05-131.37x
2026-05-121.38x
2026-05-111.34x
2026-05-081.37x
2026-05-071.39x
2026-05-061.39x
2026-05-051.39x
2026-05-041.40x
2026-05-011.42x
2026-04-301.43x
2026-04-291.41x
2026-04-281.45x
2026-04-271.46x
2026-04-241.47x
2026-04-231.47x
2026-04-221.47x
2026-04-211.45x
2026-04-201.49x
2026-04-171.51x
2026-04-161.50x
2026-04-151.52x
2026-04-141.54x
2026-04-131.53x
2026-04-101.52x
2026-04-091.53x
2026-04-081.54x
2026-04-071.51x
2026-04-061.51x
2026-04-021.51x
2026-04-011.51x
2026-03-311.51x
2026-03-301.50x
2026-03-271.52x
2026-03-261.53x
2026-03-251.53x
2026-03-241.51x
2026-03-231.52x
2026-03-201.51x
2026-03-191.52x
2026-03-181.52x
2026-03-171.54x
2026-03-161.54x
2026-03-131.52x
2026-03-121.52x
2026-03-111.55x
2026-03-101.56x
2026-03-091.58x
2026-03-061.57x
2026-03-051.60x
2026-03-041.64x
2026-03-031.66x
2026-03-021.68x
2026-02-271.67x
2026-02-261.66x
2026-02-251.66x
2026-02-241.66x
2026-02-231.69x
2026-02-201.67x
2026-02-191.68x
2026-02-181.69x
2026-02-171.66x
2026-02-131.71x
2026-02-121.73x
2026-02-111.73x
2026-02-101.73x
2026-02-091.74x
2026-02-061.75x
2026-02-051.76x
2026-02-041.74x
2026-02-031.76x
2026-02-021.75x
2026-01-301.76x
2026-01-291.73x
2026-01-281.73x
2026-01-271.72x
2026-01-261.72x
2026-01-231.73x
2026-01-221.73x
2026-01-211.72x
2026-01-201.69x
2026-01-161.67x
2026-01-151.70x
2026-01-141.70x
2026-01-131.66x
2026-01-121.67x
2026-01-091.68x
2026-01-081.70x
2026-01-071.71x
2026-01-061.72x
2026-01-051.68x
2026-01-021.66x
2025-12-311.66x
2025-12-301.67x
2025-12-291.66x
2025-12-261.66x
2025-12-241.68x
2025-12-231.68x
2025-12-221.68x
2025-12-191.69x
2025-12-181.69x
2025-12-171.69x
2025-12-161.68x
2025-12-151.69x
2025-12-121.71x
2025-12-111.71x
2025-12-101.72x
2025-12-091.71x
2025-12-081.73x
2025-12-051.73x
2025-12-041.74x
2025-12-031.74x
2025-12-021.74x
2025-12-011.76x
2025-11-281.79x
2025-11-261.78x
2025-11-251.79x
2025-11-241.76x
2025-11-211.73x
2025-11-201.71x
2025-11-191.72x
2025-11-181.73x
2025-11-171.66x
2025-11-141.66x
2025-11-131.66x
2025-11-121.66x
2025-11-111.65x
2025-11-101.61x
2025-11-071.60x
2025-11-061.57x
2025-11-051.58x
2025-11-041.58x
2025-11-031.58x
2025-10-311.58x
2025-10-301.59x
2025-10-291.60x
2025-10-281.62x
2025-10-271.63x
2025-10-241.63x
2025-10-231.63x
2025-10-221.66x
2025-10-211.66x
2025-10-201.66x
2025-10-171.66x
2025-10-161.65x
2025-10-151.65x
2025-10-141.67x
2025-10-131.65x
2025-10-101.65x
2025-10-091.67x
2025-10-081.69x
2025-10-071.69x
2025-10-061.69x
2025-10-031.68x
2025-10-021.65x
2025-10-011.64x
2025-09-301.65x
2025-09-291.63x
2025-09-261.63x
2025-09-251.63x
2025-09-241.66x
2025-09-231.64x
2025-09-221.64x
2025-09-191.65x
2025-09-181.65x
2025-09-171.64x
2025-09-161.63x
2025-09-151.62x
2025-09-121.63x
2025-09-111.63x
2025-09-101.61x
2025-09-091.63x
2025-09-081.62x
2025-09-051.61x
2025-09-041.61x
2025-09-031.61x
2025-09-021.62x
2025-08-291.61x
2025-08-281.60x
2025-08-271.60x
2025-08-261.60x
2025-08-251.58x
2025-08-221.59x
2025-08-211.57x
2025-08-201.60x
2025-08-191.55x
2025-08-181.59x
2025-08-151.59x
2025-08-141.58x
2025-08-131.59x
2025-08-121.58x
2025-08-111.59x
2025-08-081.59x
2025-08-071.57x
2025-08-061.54x
2025-08-051.55x
2025-08-041.55x
2025-08-011.54x
2025-07-311.55x
2025-07-301.57x
2025-07-291.59x
2025-07-281.58x
2025-07-251.59x
2025-07-241.58x
2025-07-231.58x
2025-07-221.57x
2025-07-211.55x
2025-07-181.55x
2025-07-171.54x
2025-07-161.55x
2025-07-151.54x
2025-07-141.55x
2025-07-111.55x
2025-07-101.54x
2025-07-091.54x
2025-07-081.53x
2025-07-071.52x
2025-07-031.53x
2025-07-021.53x
2025-07-011.53x
2025-06-301.51x
2025-06-271.50x
2025-06-261.50x
2025-06-251.49x
2025-06-241.50x
2025-06-231.49x
2025-06-201.50x
2025-06-181.51x
2025-06-171.51x
2025-06-161.54x
2025-06-131.53x
2025-06-121.55x
2025-06-111.54x
2025-06-101.54x
2025-06-091.53x
2025-06-061.53x
2025-06-051.53x
2025-06-041.51x
2025-06-031.50x
2025-06-021.48x
2025-05-301.47x
2025-05-291.46x

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway
95,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha